These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19014659)

  • 21. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectives.
    Hartley O; Martins E; Scurci I
    Swiss Med Wkly; 2018; 148():w14580. PubMed ID: 29376550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus prevention strategies in China.
    Wu ZY; Scott SR
    Chin Med J (Engl); 2020 Feb; 133(3):318-325. PubMed ID: 31929359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomedical strategies for human immunodeficiency virus (HIV) prevention? A new paradigm.
    Chan R
    Ann Acad Med Singap; 2012 Dec; 41(12):595-601. PubMed ID: 23303118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will integrase inhibitors be used as microbicides?
    Crucitti GC; Botta M; Di Santo R
    Curr HIV Res; 2012 Jan; 10(1):36-41. PubMed ID: 22264044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The struggle against AIDS: between new paradigms and inertia].
    Clumeck N
    Bull Mem Acad R Med Belg; 2010; 165(3-4):173-7; discussion 177-9. PubMed ID: 21171242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
    Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD
    Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].
    Sudre P; San Millán Ruiz D; Fagard C; Perrin L; Hirschel BJ
    Schweiz Med Wochenschr; 1999 Feb; 129(8):314-8. PubMed ID: 10189668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    ; ; ;
    MMWR Recomm Rep; 2003 Jul; 52(RR-12):1-24. PubMed ID: 12875251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
    Yombi JC; Mertes H
    AIDS Rev; 2018; 20(3):131-140. PubMed ID: 30264827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Lohse N
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men.
    Boily MC; Godin G; Hogben M; Sherr L; Bastos FI
    Med Hypotheses; 2005; 65(2):215-26. PubMed ID: 15922091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 gp120: A Target for Therapeutics and Vaccine Design.
    Cicala C; Nawaz F; Jelicic K; Arthos J; Fauci AS
    Curr Drug Targets; 2016; 17(1):122-35. PubMed ID: 26302793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.
    Lard-Whiteford SL; Matecka D; O'Rear JJ; Yuen IS; Litterst C; Reichelderfer P;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):541-52. PubMed ID: 15097296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of HIV infection in women.
    Nolte S; Sohn MA; Koons B
    J Obstet Gynecol Neonatal Nurs; 1993; 22(2):128-34. PubMed ID: 8478736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples.
    Martinez O; Wu E; Levine EC; Muñoz-Laboy M; Fernandez MI; Bass SB; Moya EM; Frasca T; Chavez-Baray S; Icard LD; Ovejero H; Carballo-Diéguez A; Rhodes SD
    PLoS One; 2016; 11(3):e0152361. PubMed ID: 27028873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of HIV prevention.
    Padian NS; Isbell MT; Russell ES; Essex M
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S22-6. PubMed ID: 22772385
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.